CAS 2095432-71-4

GSK269962 hydrochloride

CAS : 2095432-71-4

Formule : C₂₉H₃₁ClN₈O₅

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 607.0600

Ref: IN-DA01EB1E

N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(2-morpholinoethoxy)benzamide hydrochloride

CAS : 2095432-71-4

N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(2-morpholinoethoxy)benzamide hydrochloride

Degré de pureté : 99%

Masse moléculaire : 607.07g/mol

Ref: 54-OR1065270

GSK269962A hydrochloride

CAS : 2095432-71-4

GSK269962A hydrochloride (GSK 269962 hydrochloride) is a ROCK inhibitor with anti-inflammatory and vasodilatory effects and inhibits ROCK1 and ROCK2.

Formule : C₂₉H₃₁ClN₈O₅

Couleur et forme : Solid

Masse moléculaire : 607.06

Ref: TM-T39519

GSK269962A HCl

CAS : 2095432-71-4

GSK269962A HCl is a potent and selective inhibitor of Rho-associated coiled-coil containing protein kinase (ROCK), which is derived from synthetic chemical sources. This inhibitor functions by targeting the ATP-binding site of ROCK I and ROCK II isoforms, thereby blocking their kinase activity. The mode of action involves interfering with the phosphorylation of downstream substrates that are crucial for cytoskeletal dynamics.

Formule : C₂₉H₃₀N₈O₅·HCl

Degré de pureté : Min. 95%

Masse moléculaire : 607.06 g/mol

Ref: 3D-VID43271